Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 31, 2013
Royal DSM, the global Life Sciences and Materials Sciences company, today announced it has signed an agreement with the Sanquin Blood Supply Foundation (Sanquin) for the commercial manufacture of a monoclonal antibody used for the recovery and ...
read more
Wednesday, November 06, 2013
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with Opthea Pty Ltd of Melbourne, Australia.
read more
Dr. Reddy’s Laboratories and CHD Bioscience announced a global licensing agreement for the clinical development and commercialization of Dr. Reddy’s Phase III clinical trial candidate, DFA-02.
read more
Wednesday, February 19, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business.
read more
Wednesday, October 23, 2019
Dr. Reddy’s confirms it initiated a voluntary nationwide recall of all of its ranitidine medications sold in US due to confirmed contamination with NDMA above levels established by the FDA.
read more
Dr. Reddy’s and its subsidiary, Promius Pharma announced the filing of NDA for its migraine candidate DFN-02 with the FDA.
read more
Dr. Reddy’s Laboratories has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology.
read more
Dr. Reddy’s Laboratories has entered into a definitive agreement for the sale of its API manufacturing business unit located in Jeedimetla, Hyderabad, to Therapiva Private, a generics pharmaceutical company.
read more
Thursday, February 21, 2019
Dr. Reddy’s announced the re-launch of its Buprenorphine and Naloxone Sublingual Film, a therapeutic equivalent generic version of Suboxone sublingual film, in the U.S. market.
read more
Dr. Reddy’s Laboratories announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin® for Injection.
read more
Tuesday, January 15, 2019
Pharmaceutics International, Inc. (Pii) announced the appointment of Kurt R. Nielsen, Ph.D., to the position of President and CEO, effective immediately.
read more
Thursday, October 17, 2013
Pharmaceutical contract development and manufacturing organizations (CDMOs) DPT Laboratories, based in San Antonio, Texas, and Confab, based in Saint-Hubert, Quebec, today announced the integration of the organizations under the leadership of Paul ...
read more
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today an exclusive manufacturing license and supply agreement that will allow Sigma-Aldrich to manufacture...
read more
Tuesday, January 14, 2020
Valneva announced the U.S. Department of Defense has exercised an option to purchase 80,000 additional doses of its Japanese encephalitis vaccine IXIARO®.
read more
Thursday, December 02, 2021
Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must ...
read more